Mobile Site ›

Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

An Update


Receive notification when new Hot Topics are published:

Clinical Utility of AGID Evaluation

Slide 16

April 2012

So what are the appropriate clinical circumstances to do the autoimmune gastrointestinal dysmotility serological evaluation?  There are 5 specific uses for this testing. Firstly, this could be used for investigating acquired idiopathic gastrointestinal dysmotility to see if an idiopathic autoimmune or paraneoplastic basis can be established for this. This can then help direct treatment. If 1 or more of the antibodies described were detected, this may increase the clinician’s confidence that a trial of immunosuppression is warranted. Thirdly, the antibody profile detected can help predict the cancer type. Fourthly, this testing can be used to investigate gastrointestinal dysmotility occurring during cancer therapy that was not explainable by recurrent cancer or metastasis.

Clinical Utility of AGID Evaluation


Jump to section: